FDA inspection
UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program: FDA inspection ending Jun 19, 2019
FDA inspection 1100640 · No Action Indicated (NAI) · Los Angeles, CA
Key facts
| Inspection ID | 1100640 |
|---|---|
| Firm | UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program |
| FEI number | 2074237 |
| Address | 10833 Le Conte Ave Rm A4-239 |
| City | Los Angeles |
| State | CA |
| ZIP | 90095 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Jun 19, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data